0.5g / 5 Ml, Poudre Et Solvantpour Solution Injectable (IM/IV) /Powder and Solvent for Solutionfor Injection (IM/IV) Ceftriaxone Injection
Model No.: Am160525-09
Ceftriaxone injection is often used (in combination, but not direct, with macrolide and/or
aminoglycoside antibiotics) for the treatment of community-acquired or mild to moderate health care-associated pneumonia. It is also a choice drug for treatment of bacterial meningitis. In pediatrics, it is
commonly used in febrile infants between 4 and 8 weeks of age who are admitted to the hospital to
Ceftriaxone injection is contraindicated in neonates if they require (or are expected to require)
treatment with calcium-containing IV solutions, including continuous calcium-containing infusions such as parenteral nutrition because of the risk of precipitation of ceftriaxone-calcium.
Hypoprothrombinaemia and bleeding are specific side effects. Haemolysis is reported. Biliary sludging is another known though rare adverse effect which occurs primarily in neonates.
Ceftriaxone can interact with a number of medicines. Drugs that can interact with ceftriaxone include, but are not limited to, the following: Warfarin, Probenecid, Sulfinpyrazone, Calcium.
Precautions & Warning:
Before therapy with ceftriaxone for injection is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to cephalosporins, penicillins or
other drugs. this product should be given cautiously to penicillin-sensitive patients. antibiotics should be administered with caution to any patient who has demonstrated some form of allergy, particularly to drugs. serious acute hypersensitivity reactions may require
the use of subcutaneous epinephrine and other emergency measures.
Use in Pregnancy and Nursing Mothers:
Ceftriaxone is excreted into human milk in small amounts. Ceftriaxone is considered compatible with breast-feeding by the American Academy of Pediatrics. The manufacturer recommends that caution be used when administering ceftriaxone to nursing women.
Treatment/antidote in The Event of Overdose:
In the case of overdosage, drug concentration would not be reduced by hemodialysis or peritoneal
dialysis. There is no specific antidote. Treatment of overdosage should be symptomatic.
Store below 25 degrees celsius. Protect from moisture. Keep out of reach of children.
Validity: Three Years
Contact us if you need more details on Ceftriaxone Injection. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Ceftriaxone、Im/IV. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Medical Antibiotics